Our result shows that the administration of IL-22 evidently improved ovarian function and alleviated hyperandrogenism in this non-metabolic PCOS mouse model, indicating that IL-22 could directly target PCOS ovaries to modulate the process of follicle development and ovulation. Here, IL22 is linked to polycystic ovary syndrome.